-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*For medical professionals to read and reference Xueba Challenge, waiting for you! Among these diseases, those that are not diffuse connective tissue diseases are A.
Dermatomyositis B.
Rheumatoid Arthritis C.
Ankylosing Spondylitis D.
Systemic Lupus Erythematosus E.
Sjögren's Syndrome Previous Answer: E Analysis: Glucocorticoids At present, it is still the most commonly used and effective drug for the treatment of SLE.
It is suitable for acute fulminant SLE and/or SLE with important organs such as kidney, central nervous system, cardiopulmonary and hemolytic anemia
.
The most commonly used prednisone, the dose is 1 mg per kilogram of body weight per day, the dose can be doubled in severe cases, and 0.
5 mg per kilogram of body weight per day in mild cases
.
The general treatment is 4-6 weeks, and the dosage will be reduced after the condition has improved significantly
.
Link to previous article: Female patients with anemia and positive anti-double-stranded DNA antibodies, what is the preferred drug for treatment?
Dermatomyositis B.
Rheumatoid Arthritis C.
Ankylosing Spondylitis D.
Systemic Lupus Erythematosus E.
Sjögren's Syndrome Previous Answer: E Analysis: Glucocorticoids At present, it is still the most commonly used and effective drug for the treatment of SLE.
It is suitable for acute fulminant SLE and/or SLE with important organs such as kidney, central nervous system, cardiopulmonary and hemolytic anemia
.
The most commonly used prednisone, the dose is 1 mg per kilogram of body weight per day, the dose can be doubled in severe cases, and 0.
5 mg per kilogram of body weight per day in mild cases
.
The general treatment is 4-6 weeks, and the dosage will be reduced after the condition has improved significantly
.
Link to previous article: Female patients with anemia and positive anti-double-stranded DNA antibodies, what is the preferred drug for treatment?
